More on DHR
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $211.03 |
|
|||
| Open | $207.19 | ||||
| 52 Wk High | $102.79 | ||||
| 52 Wk Low | $75.71 | ||||
| Day High | $208.70 | ||||
| Day Low | $205.23 | ||||
| P/E | 54.65 | ||||
| EPS | $3.80 | ||||
| Volume | 2,898,130 | ||||
- WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC
- Danaher (DHR) PT Raised to $238 at Baird
- Danaher (DHR) PT Raised to $250 at HSBC
- Morgan Stanley sees Waters best positioned after China lab pricing rules
- Form 4 DANAHER CORP /DE/ For: Aug 21 Filed by: Blair Rainer
- Form 144 DANAHER CORP /DE/ Filed by: Blair Rainer
- Integrated DNA Technologies Defines the Next Era of DNA Synthesis: Full-Spectrum Capabilities for Speed, Complexity and Scale
- Danaher (DHR) call put ratio 1.1 calls to 1 put as share price up 4.8%
- Danaher (DHR) call put ratio 1.3 calls to 1 put
- Form 4 DANAHER CORP /DE/ For: Aug 04 Filed by: Riley Christopher Paul
Entities mentioned with DHR
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Danaher/Beckman Coulter | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
